- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT03568981
Impact of 5-fraction Stereotactic Partial Breast Irradiation and Whole Breast Irradiation on Cosmetic Outcome and Patient-reported Outcomes in Early-stage Breast Cancer
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Tipo de estudo
Inscrição (Antecipado)
Contactos e Locais
Contato de estudo
- Nome: Yong Bae Kim, MD, PhD
- Número de telefone: 82-2228-8095
- E-mail: ybkim3@yuhs.ac
Locais de estudo
-
-
Korea
-
Seoul, Korea, Republica da Coréia, 120-752
- Recrutamento
- Severance Hospital
-
Contato:
- YongBae Kim, MD
- Número de telefone: 82-10-6256-2592
- E-mail: ybkim3@yuhs.ac
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Método de amostragem
População do estudo
Descrição
Inclusion Criteria:
- Pathologically confirmed invasive breast carcinoma or ductal carcinoma in situ (DCIS)
- Women who underwent breast-conservating surgery and have a plan to undergoing partial or whole breast irradiation
- Good performance status (ECOG 0-1)
Exclusion Criteria:
- Recurrent breast cancer
- History of ipsilateral breast irradiation
- Positive resection margin status after breast surgery
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
Coortes e Intervenções
Grupo / Coorte |
Intervenção / Tratamento |
---|---|
Partial Breast Irradiation (PBI)
Patients receiving 5-fraction stereotactic partial breast irradiation for breast cancer
|
After breast- conservating surgery, all patients are allowed to receive partial breast irradiation or whole breast irradiation after surgery according to the international guidelines and physician's discretion.
|
Whole Breast Irradiation (WBI)
Patients receiving whole breast irradiation for breast cancer
|
After breast- conservating surgery, all patients are allowed to receive partial breast irradiation or whole breast irradiation after surgery according to the international guidelines and physician's discretion.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Change of patient reported psychosocial functioning score
Prazo: Before radiotherapy (allowed to 8 weeks before radiotherapy)
|
Patient reported psychosocial functioning measured in 7 point Likert scale
|
Before radiotherapy (allowed to 8 weeks before radiotherapy)
|
Change of patient reported psychosocial functioning score
Prazo: 2 year after radiotherapy (allowed to plus 8 weeks)
|
Patient reported psychosocial functioning measured in 7 point Likert scale
|
2 year after radiotherapy (allowed to plus 8 weeks)
|
Change of patient reported patient treatment satisfaction score
Prazo: Before radiotherapy (allowed to 8 weeks before radiotherapy)
|
Patient reported patient treatment satisfaction measured in 7 point Likert scale
|
Before radiotherapy (allowed to 8 weeks before radiotherapy)
|
Change of patient reported patient treatment satisfaction score
Prazo: 2 year after radiotherapy (allowed to plus 8 weeks)
|
Patient reported patient treatment satisfaction measured in 7 point Likert scale
|
2 year after radiotherapy (allowed to plus 8 weeks)
|
Change of patient reported physical functioning score
Prazo: Before radiotherapy (allowed to 8 weeks before radiotherapy)
|
Patient reported physical functioning measured in 7 point Likert scale
|
Before radiotherapy (allowed to 8 weeks before radiotherapy)
|
Change of patient reported physical functioning score
Prazo: 2 year after radiotherapy (allowed to plus 8 weeks)
|
Patient reported physical functioning measured in 7 point Likert scale
|
2 year after radiotherapy (allowed to plus 8 weeks)
|
Change of patient reported body image score
Prazo: Before radiotherapy (allowed to 8 weeks before radiotherapy)
|
Patient reported body image score measured in 7 point Likert scale
|
Before radiotherapy (allowed to 8 weeks before radiotherapy)
|
Change of patient reported body image score
Prazo: 2 year after radiotherapy (allowed to plus 8 weeks)
|
Patient reported body image score measured in 7 point Likert scale
|
2 year after radiotherapy (allowed to plus 8 weeks)
|
Change of breast cosmesis measures (excellent/good/poor)
Prazo: Before radiotherapy (allowed to 8 weeks before radiotherapy
|
breast cosmesis result is measures by BCCT.core (Breast Cancer Conservative Treatment cosmetic results) software - Investigators will whether there are any changes on patient-reported outcomes, cosmetic outcome, and breast tissue fibrosis after radiotherapy. Any differences of theses parameters according to the radiotherapy techniques (PBI vs. WBI) will be examed. |
Before radiotherapy (allowed to 8 weeks before radiotherapy
|
Change of breast cosmesis measures (excellent/good/poor)
Prazo: 2 year after radiotherapy (allowed to plus 8 weeks)
|
breast cosmesis result is measures by BCCT.core (Breast Cancer Conservative Treatment cosmetic results) software
|
2 year after radiotherapy (allowed to plus 8 weeks)
|
Change of breast-tissue fibrosis measures (gram)
Prazo: Before radiotherapy (allowed to 8 weeks before radiotherapy
|
breast-tissue fibrosis is measured by tissue compliance meter device.
|
Before radiotherapy (allowed to 8 weeks before radiotherapy
|
Change of breast-tissue fibrosis measures (gram)
Prazo: 2 year after radiotherapy (allowed to plus 8 weeks)
|
breast-tissue fibrosis is measured by tissue compliance meter device.
|
2 year after radiotherapy (allowed to plus 8 weeks)
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Incidence of Radiotherapy-related complications
Prazo: Before radiotherapy (allowed to 8 weeks before radiotherapy)
|
Investigators will check whether there are any kinds of radiotherapy-related complications after PBI or WBI.
Any differences of complications according to the radiotherapy techniques will be examed.
|
Before radiotherapy (allowed to 8 weeks before radiotherapy)
|
Incidence of Radiotherapy-related complications
Prazo: 2 year after radiotherapy (allowed to plus 8 weeks)
|
Investigators will check whether there are any kinds of radiotherapy-related complications after PBI or WBI.
Any differences of complications according to the radiotherapy techniques will be examed.
|
2 year after radiotherapy (allowed to plus 8 weeks)
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Antecipado)
Conclusão do estudo (Antecipado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 4-2018-0160
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Câncer de mama
-
Turku University HospitalLounais-Suomen SyöpäyhdistysAinda não está recrutandoSobrevivente de cancerFinlândia
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)RetiradoSobrevivente de cancerEstados Unidos
-
University of Alabama at BirminghamNational Cancer Institute (NCI); Auburn UniversityConcluído
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)ConcluídoSobrevivente de cancerEstados Unidos
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)ConcluídoSobrevivente de cancerEstados Unidos, Guam
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); National Institute of Mental Health (NIMH)ConcluídoSobrevivente de cancerEstados Unidos
-
Masonic Cancer Center, University of MinnesotaConcluídoSobrevivente de cancerEstados Unidos
-
University of New MexicoNew Mexico State University; University of New Mexico Cancer CenterConcluído
-
Ohio State University Comprehensive Cancer CenterConcluídoSobrevivente de cancerEstados Unidos
-
Abramson Cancer Center of the University of PennsylvaniaConcluídoPlano de cuidados de sobrevivência LIVESTRONG: coleta contínua de dados e pesquisa de acompanhamentoPaciente com cancerEstados Unidos
Ensaios clínicos em Partial breast irradiation
-
Zimmer BiometAtivo, não recrutandoOsteoartrite | Necrose avascular | Artrite Traumática | Fraturas condicionais do côndilo tibial ou do platô | Revisão Condicional da Superfície ArticularReino Unido, Espanha, Estados Unidos, Itália, Suécia, Bélgica, Áustria, França, Alemanha, Suíça
-
Medical University of GrazConcluídoQualidade de vida | Satisfação, Paciente | Complicações Pós-Operatórias/PerioperatóriasÁustria
-
Thurgau Breast CenterRecrutamento
-
Royal Marsden NHS Foundation TrustDesconhecidoCâncer de mamaReino Unido
-
Abramson Cancer Center of the University of PennsylvaniaConcluídoNódulo de mama sintomáticoEstados Unidos
-
University of Nove de JulhoAinda não está recrutandoBruxismo do sono | Bruxismo do Sono, Infância
-
Memorial Sloan Kettering Cancer CenterAtivo, não recrutandoCâncer de mamaEstados Unidos
-
Stanford UniversityConcluídoCarcinoma de mama | Distúrbio da mamaEstados Unidos
-
Memorial Sloan Kettering Cancer CenterAtivo, não recrutando
-
Golden Jubilee National HospitalInscrevendo-se por convite